Oncogene - Table of Contents alert Volume 35 Issue 23

If you are unable to see the message below, click here to view.

Advertisement Culture your cells in 3D Enhance your epigenetics research using 3D micro pattern cell culture plates  Biologically relevant: Adherent cells form natural spheroids to measure of cell-to-cell interactions Ready-to-use: No expertise required - use right out of the box! Diverse: ChIP-seq, drug/inhibitor screening, toxicity assays, cell differentiation, and more  Learn more TABLE OF CONTENTS Volume 35, Issue 23 (June 2016) In this issue Review Original Articles Short Communication Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement View most cited articles - which ones have you missed? Take a look at what your colleagues have been citing across the Oncogene journal over the past two years.  Click here to visit special webpage Review Top The EGFR-HER2 module: a stem cell approach to understanding a prime target and driver of solid tumors M R Schneider and Y Yarden Oncogene 2016 35: 2949-2960; advance online publication, October 5, 2015; 10.1038/onc.2015.372 Abstract | Full Text Original Articles Top PIK3CAH1047R- and Her2-initiated mammary tumors escape PI3K dependency by compensatory activation of MEK-ERK signaling H Cheng, P Liu, C Ohlson, E Xu, L Symonds, A Isabella, W J Muller, N U Lin, I E Krop, T M Roberts, E P Winer, C L Arteaga and J J Zhao Oncogene 2016 35: 2961-2970; advance online publication, December 7, 2015; 10.1038/onc.2015.377 Abstract | Full Text Identification of an orally available compound with potent and broad FLT3 inhibition activity Y Chen, Y Guo, W Zhao, W-T Tina Ho, X Fu and Z J Zhao Oncogene 2016 35: 2971-2978; advance online publication, September 28, 2015; 10.1038/onc.2015.362 Abstract | Full Text Hepatitis C virus upregulates B-cell receptor signaling: a novel mechanism for HCV-associated B-cell lymphoproliferative disorders OPEN B Dai, A Y Chen, C P Corkum, R J Peroutka, A Landon, S Houng, P A Muniandy, Y Zhang, E Lehrmann, K Mazan-Mamczarz, J Steinhardt, M Shlyak, Q C Chen, K G Becker, F Livak, T I Michalak, R Talwani and R B Gartenhaus Oncogene 2016 35: 2979-2990; advance online publication, October 5, 2015; 10.1038/onc.2015.364 Abstract | Full Text SPROUTY-2 represses the epithelial phenotype of colon carcinoma cells via upregulation of ZEB1 mediated by ETS1 and miR-200/miR-150 A Barbáchano, A Fernández-Barral, F Pereira, M F Segura, P Ordóñez-Morán, E Carrillo-de Santa Pau, J M González-Sancho, D Hanniford, N Martínez, A Costales-Carrera, F X Real, H G Pálmer, J M Rojas, E Hernando and A Muñoz Oncogene 2016 35: 2991-3003; advance online publication, October 12, 2015; 10.1038/onc.2015.366 Abstract | Full Text PAT4 levels control amino-acid sensitivity of rapamycin-resistant mTORC1 from the Golgi and affect clinical outcome in colorectal cancer OPEN S-J Fan, C Snell, H Turley, J-L Li, R McCormick, S M W Perera, S Heublein, S Kazi, A Azad, C Wilson, A L Harris and D C I Goberdhan Oncogene 2016 35: 3004-3015; advance online publication, October 5, 2015; 10.1038/onc.2015.363 Abstract | Full Text AP2α controls the dynamic balance between miR-126&126* and miR-221&222 during melanoma progression OPEN N Felli, M C Errico, F Pedini, M Petrini, R Puglisi, M Bellenghi, A Boe, F Felicetti, G Mattia, A De Feo, L Bottero, C Tripodo and A Carè Oncogene 2016 35: 3016-3026; advance online publication, October 5, 2015; 10.1038/onc.2015.357 Abstract | Full Text Exosomes mediate the acquisition of the disease phenotypes by cells with normal genome in tuberous sclerosis complex B Patel, J Patel, J-H Cho, S Manne, S Bonala, E Henske, F Roegiers, M Markiewski and M Karbowniczek Oncogene 2016 35: 3027-3036; advance online publication, October 5, 2015; 10.1038/onc.2015.358 Abstract | Full Text Metabolic targeting of oncogene MYC by selective activation of the proton-coupled monocarboxylate family of transporters L Gan, R Xiu, P Ren, M Yue, H Su, G Guo, D Xiao, J Yu, H Jiang, H Liu, G Hu and G Qing Oncogene 2016 35: 3037-3048; advance online publication, October 5, 2015; 10.1038/onc.2015.360 Abstract | Full Text INPP4B is an oncogenic regulator in human colon cancer OPEN S T Guo, M N Chi, R H Yang, X Y Guo, L K Zan, C Y Wang, Y F Xi, L Jin, A Croft, H-Y Tseng, X G Yan, M Farrelly, F H Wang, F Lai, J F Wang, Y P Li, S Ackland, R Scott, I U Agoulnik, H Hondermarck, R F Thorne, T Liu, X D Zhang and C C Jiang Oncogene 2016 35: 3049-3061; advance online publication, September 28, 2015; 10.1038/onc.2015.361 Abstract | Full Text The role of APC/CCdh1 in replication stress and origin of genomic instability C Greil, J Krohs, D Schnerch, M Follo, J Felthaus, M Engelhardt and R Wäsch Oncogene 2016 35: 3062-3070; advance online publication, October 12, 2015; 10.1038/onc.2015.367 Abstract | Full Text Somatic human ZBTB7A zinc finger mutations promote cancer progression X-S Liu, Z Liu, C Gerarduzzi, D E Choi, S Ganapathy, P P Pandolfi and Z-M Yuan Oncogene 2016 35: 3071-3078; advance online publication, October 12, 2015; 10.1038/onc.2015.371 Abstract | Full Text Short Communication Top DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia OPEN H J Ferreira, H Heyn, M Vizoso, C Moutinho, E Vidal, A Gomez, A Martínez-Cardús, L Simó-Riudalbas, S Moran, E Jost and M Esteller Oncogene 2016 35: 3079-3082; advance online publication, October 5, 2015; 10.1038/onc.2015.359 Abstract | Full Text Advertisement BioPharma Dealmakers  A supplement to Nature Biotechnology & Nature Reviews Drug Discovery Sign up to our NEW networking forum to connect with life sciences companies and partnering professionals looking for dealmaking opportunities.  Stay up to date on emerging therapeutic areas  Ask for advice from our editors and experts in the field SIGN UP NOW Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.